The nation of Zimbabwe has declined a substantial American healthcare agreement valued at $367m (272 million pounds) over five years due to the United States' request for sensitive information.
This rejection was revealed after a internal memorandum from December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "lopsided".
An official spokesperson later stated that the US was demanding access to biological samples for research and profit while was not willing to share the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued negotiations to reach a deal acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Context
This rejection follows a similar situation in Kenya, where a court halted a similar health funding agreement following legal challenges were raised about the safety of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump stated its expenditure was "wasteful" and his government was seeking direct bilateral deals to enhance openness and responsibility.
According to reports, 16 African countries have to date agreed to similar agreements, representing over $18.3bn of fresh investment.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, without any equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," he stated.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our population should a new disease outbreak arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending frameworks already set up via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This system is intended to ensure that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome ongoing discussions with our US partners on how future collaboration could be arranged in a way that honours the independence and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that negotiations should continue since a large portion of the country's HIV programmes relied on international support.
"If technical issues exist, such as those relating to information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it commented.
The halted deal highlights the ongoing debate between receiving crucial foreign assistance and protecting a country's data in an increasingly interconnected world.